AMANDA RAUH: Open Payments
NPI 1710667803 · GRETNA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 110 payments from 25 companies in 2025. Trend: 2023 $499 · 2024 $1,668 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $349 |
| Amgen Inc. | 12 | $235 |
| Otsuka America Pharmaceutical, Inc. | 12 | $144 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| Lilly USA, LLC | 13 | $142 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Antares Pharma, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, REXULTI, REPATHA, HETLIOZ, KISUNLA, UBRELVY, OTEZLA, Kerendia.
Industry payments across NE — which companies pay providers there.
